A physiologically based pharmacokinetic (PBPK) parent-metabolite model of the chemotherapeutic zoptarelin doxorubicin-integration of in vitro results, Phase I and Phase II data and model application for drug-drug interaction potential analysis.
about
A physiologically based pharmacokinetic (PBPK) parent-metabolite model of the chemotherapeutic zoptarelin doxorubicin-integration of in vitro results, Phase I and Phase II data and model application for drug-drug interaction potential analysis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A physiologically based pharma ...... nteraction potential analysis.
@en
A physiologically based pharma ...... nteraction potential analysis.
@nl
type
label
A physiologically based pharma ...... nteraction potential analysis.
@en
A physiologically based pharma ...... nteraction potential analysis.
@nl
prefLabel
A physiologically based pharma ...... nteraction potential analysis.
@en
A physiologically based pharma ...... nteraction potential analysis.
@nl
P2093
P2860
P1476
A physiologically based pharma ...... interaction potential analysis
@en
P2093
Babette Aicher
Daniel Moj
Hannah Britz
Herbert Sindermann
Michael Teifel
Nicola Ammer
Nina Hanke
Thorsten Lehr
P2860
P2888
P304
P356
10.1007/S00280-017-3495-2
P577
2017-12-04T00:00:00Z